Health ❯ Healthcare ❯ Diabetes

Obesity

Clinical Trials Weight Loss Treatments

Biomea Fusion Prices Equity Offering With Warrants to Raise About $25 Million

Closing is slated for Oct. 8 pending customary conditions under the company’s effective shelf registration.

Amgen Advances Monthly Obesity Drug to Phase 3 After 20% Weight Loss in Mid-Stage Trial